Muscle function and omega-3 fatty acids in the prediction of lean body mass after breast cancer treatment

SpringerPlus

Volumn 2, Issue 1, 2013, Pages

  McDonald, Cameron ^a   Bauer, Judy ^a   Capra, Sandra ^a   Waterhouse, Mary ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Breast cancer; Exercise; Fitness; Lean body mass; Nutrition; Omega 3 fatty acids

Indexed keywords

EID: 84891470869     PISSN: None     EISSN: 21931801     Source Type: Journal    
DOI: 10.1186/2193-1801-2-681     Document Type: Article

References (49)

1. American College of Sports Medicine (2010) ACSM's Guidelines for Exercise Testing and Prescription, 8th edn. Wolters Kluwer/Lippincott Williams & Wilkins, Philadelphia
2. Campbell K.L., Lane K, Martin AD et al (2007) Resting Energy Expenditure and Body Mass Changes in Women During Adjuvant Chemotherapy for Breast Cancer. Cancer Nursing 30:95-100
3. Cella D., Tulsky D, Gray G et al (1993) The Functional Assessment of Cancer Therapy scale: Development and validation of the general measure. J Clin Oncol 11:570-579
4. Cerchietti L.C.A., Naviganteac AH, Castroa MA (2007) Effects of Eicosapentaenoic and Docosahexaenoic n-3 Fatty Acids From Fish Oil and Preferential Cox-2 Inhibition on Systemic Syndromes in Patients With Advanced Lung Cancer. Nutr Cancer 59:14-20
5. Cheney C.L., Mahloch J, Freeny P (1994) Computerised tomography assessment of women with weight changes associated with adjuvant treatment for breast cancer. Am J Clin Nutr 66:141-146
6. Chlebowski R.T., Aiello E, Mctiernan A (2002) Weight Loss in Breast Cancer Patient Management. J Clin Oncol 20:1128-1143
7. Courneya K.S., Segal RJ, Mackey JR et al (2007) Effects of Aerobic and Resistance Exercise in Breast Cancer Patients Receiving Adjuvant Chemotherapy: A Multicenter Randomized Controlled Trial. J Clin Oncol 25:4396-4404
8. Demark-Wahnefried W, Hars V, Conaway MR et al (1997) Reduced rates of metabolism and decreased physical activity in breast cancer patients receiving adjuvant chemotherapy. Am J Clin Nutr 65:1495-1501
9. Demark-Wahnefried W, Peterson BL, Winer EP et al (2001) Changes in Weight, Body Composition, and Factors Influencing Energy Balance Among Premenopausal Breast Cancer Patients Receiving Adjuvant Chemotherapy. Journal of Clinical Oncology 19:2381-2389
10. Dewey A., Baughan C, Dean T, Higgins B, Johnson I (2007) Eicosapentaenoic acid (EPA, an omega-3 fatty acid from fish oils) for the treatment of cancer cachexia. The Cochrane database of systematic reviews (1469-493X) 1:CD004597
11. Fearon K.C.H., Barber MD, Moses AG et al (2006) Double-Blind, Placebo-Controlled, Randomized Study of Eicosapentaenoic Acid Diester in Patients With Cancer Cachexia. Journal of Clinical Oncology 24:3401-3407
12. Fearon K.C.H., Von Meyenfeldt MF, Moses AGW et al (2003) Effect of a protein and energy dense n-3 fatty acid enriched oral supplement on loss of weight and lean tissue in cancer cachexia: a randomised double blind trial. Gut 52:1479-1486
13. Francini G., Petrioli R, Montagnani A et al (2006) Exemestane after tamoxifen as adjuvant hormonal therapy in postmenopausal women with breast cancer: effects on body composition and lipids. Br J Cancer 95:153-158
14. Gordon A.M., Hurwitz S, Shapiro CL et al (2011) Premature ovarian failure and body composition changes with adjuvant chemotherapy for breast cancer. Menopause 18:1244
15. Healy L.A., Ryan AM, Carroll P et al (2010) Metabolic Syndrome, Central Obesity and Insulin Resistance are Associated with Adverse Pathological Features in Postmenopausal Breast. Clinical Oncology 22:281-288
16. Ibrahim E.M., Al-Homaidh A (2011) Physical activity and survival after breast cancer diagnosis: meta-analysis of published studies. 28(3):65-753. doi:doi: 10.1007/s12032-010-9536-x. Epub 2010 Apr 22
17. Irwin M.L., Alvarez-Reeves M, Cadmus L et al (2009) Exercise Improves Body Fat, Lean Mass, and Bone Mass in Breast Cancer Survivors. Obesity 17:1534-1541
18. Irwin M.L., Crumley D, Mctiernan A et al (2003) Physical activity levels before and after a diagnosis of breast carcinoma. Cancer 97:1746-1757
19. Irwin M.L., Mctiernan A, Baumgartner RN et al (2005) Changes in body fat and weight after a breast cancer diagnosis: influence of demographic, prognostic, and lifestyle factors. Journal of Clinical Oncology 23:774-782
20. Krebs J.D., Browning LM, Mclean NK et al (2006) Additive benefits of long-chain n-3 polyunsaturated fatty acids and weight-loss in the management of cardiovascular disease risk in overweight hyperinsulinaemic women. Int J Obes 30:1535-1544
21. Kutynec C.I., Mccargar L, Barr SI et al (1999) Energy balance in women with breast cancer during adjuvant treatment. Journal of the American Dietetic Association 99:1222-1227
22. Martin GS (2004) The interviewer-administered, open-ended diet history method for assessing usual dietary intakes in clinical research: relative and criterion validation studies. In: University of Wollongong Thesis Collection. University of Wollongong, Wollongong
23. Mcdonald C., Bauer JM, Capra S et al (2013a) The Muscle mass, Omega-3, Diet, Exercise and Lifestyle (MODEL) study-study protocol for a randomised controlled trial for women who have completed breast cancer treatment. BMC Cancer, In Press
24. Mcdonald C.K., Bauer JD, Capra S (2011) Body Composition and Breast Cancer-the Role of Lean Body Mass. Cancer Forum 35:102-106
25. Mcdonald C.K., Bauer JD, Capra S (2013b) Omega-3 fatty acids and changes in LBM-alone or in synergy for better muscle health? A Review. Canadian Journal of Physiology and Pharmacology, in press
26. Mcneely M.L., Campbell KL, Rowe BH et al (2006) Effects of exercise on breast cancer patients and survivors: a systematic review and meta-analysis. CMAJ: Canadian Medical Association Journal 175:34-41
27. Montagnani A., Gonnelli S, Cadirni A et al (2008) The effects on lipid serum levels of a 2-year adjuvant treatment with exemestane after tamoxifen in postmenopausal women with early breast cancer. European Journal of Internal Medicine 19:592-597
28. Moses A.W., Slater C, Preston T et al (2004) Reduced total energy expenditure and physical activity in cachectic patients with pancreatic cancer can be modulated by an energy and protein dense oral supplement enriched with n-3 fatty acids. Br J Cancer 90:996-1002
29. Mourtzakis M., Bedbrook M (2009) Muscle atrophy in cancer: a role for nutrition and exercise. Applied Physiology, Nutrition and Metabolism 34:950-956
30. Murphy R.A., Mourtzakis M, Chu QS et al (2010) Skeletal Muscle Depletion Is Associated with Reduced Plasma (n-3) Fatty Acids in Non-Small Cell Lung Cancer Patients. The Journal of Nutrition 140:1602-1606
31. Murphy R.A., Mourtzakis M, Chu QSC et al (2011) Nutritional intervention with fish oil provides a benefit over standard of care for weight and skeletal muscle mass in patients with nonsmall cell lung cancer receiving chemotherapy. Cancer 117:1775-1782
32. Murphy R.A., Mourtzakis M, Mazurak VC (2012) n-3 polyunsaturated fatty acids: the potential role for supplementation in cancer. Current opinion in clinical nutrition and metabolic care 15:246
33. Newman A.B., Kupelian V, Visser M et al (2006) Strength, But Not Muscle Mass, Is Associated With Mortality in the Health, Aging and Body Composition Study Cohort. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences 61:72-77
34. Noreen Eric E, Sass Michael J, Crowe Megan L, Pabon Vanessa A, Brandauer J, Averill Lindsay K (2010) Effects of supplemental fish oil on resting metabolic rate, body composition, and salivary cortisol in healthy adults. Journal of the International Society of Sports Nutrition, ISSN 1550-2783 7(1):31
35. Pedersen B.K., Febbraio MA (2012) Muscles, exercise and obesity: skeletal muscle as a secretory organ. Nature reviews Endocrinology 8:457
36. Pierce B.L., Ballard-Barbash R, Bernstein L et al (2009) Elevated Biomarkers of Inflammation Are Associated With Reduced Survival Among Breast Cancer Patients. J Clin Oncol 27:3437-3444
37. Prado C.M.M., Baracos VE, Mccargar LJ et al (2009) Sarcopenia as a Determinant of Chemotherapy Toxicity and Time to Tumor Progression in Metastatic Breast Cancer Patients Receiving Capecitabine Treatment. Clinical Cancer Research 15:2920-2926
38. Ries A., Trottenberg P, Elsner F et al (2012) A systematic review on the role of fish oil for the treatment of cachexia in advanced cancer: an EPCRC cachexia guidelines project. Palliat Med 26:294-304
39. Rodacki C.L., Rodacki AL, Pereira G et al (2012) Fish-oil supplementation enhances the effects of strength training in elderly women. The American Journal of Clinical Nutrition 95:428-436
40. Ruiz J.R., Sui X, Lobelo F et al (2008) Association between muscular strength and mortality in men: prospective cohort study. British Medical Journal (Clinical Research Ed) 337:a439-495
41. Schmitz K.H., Ahmed RL, Hannan PJ et al (2005) Safety and Efficacy of Weight Training in Recent Breast Cancer Survivors to Alter Body Composition, Insulin, and Insulin-Like Growth Factor Axis Proteins. Cancer Epidemiology, Biomarkers & Prevention 14:1672-1680
42. Sharman A., Stowasserb M (2009) Australian Association for Exercise and Sports Science Position Statement on Exercise and Hypertension. Journal of Science and Medicine in Sport 12:252-257
43. Sheean P.M., Hoskins K, Stolley M (2012) Body composition changes in females treated for breast cancer: a review of the evidence. Breast Cancer Res Treat 135:663-680
44. Smith G.I., Atherton P, Reeds DN et al (2011a) Dietary omega-3 fatty acid supplementation increases the rate of muscle protein synthesis in older adults: a randomized controlled trial. Am J Clin Nutr 93:402-412
45. Smith G.I., Atherton P, Reeds DN et al (2011b) Omega-3 polyunsaturated fatty acids augment the muscle protein anabolic response to hyperinsulinaemia-hyperaminoacidaemia in healthy young and middle-aged men and women. Clinical science (London, England: 1979) 121:267-278
46. Storlien L.H., Robertson RM, Hill JO et al (2001) Role of weight loss and polyunsaturated fatty acids in improving metabolic fitness in moderately obese, moderately hypertensive subjects. J Hypertens 19:1745-1754
47. Van Der Meij BS, Van Bokhorst-De Van Der Schueren MA, Langius JA et al (2011) n-3 PUFAs in cancer, surgery, and critical care: a systematic review on clinical effects, incorporation, and washout of oral or enteral compared with parenteral supplementation. The American Journal of Clinical Nutrition 94:1248-1265
48. Van Londen G, Perera S, Vujevich K et al (2011) The impact of an aromatase inhibitor on body composition and gonadal hormone levels in women with breast cancer. Breast Cancer Res Treat 125:441-446
49. Winters-Stone KM, Nail L, Bennett JA et al (2009) Bone health and falls: fracture risk in breast cancer survivors with chemotherapy-induced amenorrhea. Oncology Nursing Forum 36:315-325